Skip to content

Philotax

Active Private limited companyfounded 2024active for 2 yearsWittemoerstraat 2, 8730 BeernemKBO/BCE: BE 1014.546.160

Lifetime

2 annual accounts with figures on one time axis
peak €100,875 (2025)
€100,875▲ 519%
peak €79,311 (2025)
€79,311▲ 520%
peak €94,600 (2025)
€94,600▲ 519%
€22,516▲ 35.9%
Board1 name since 2024
Documentsfilings and deeds
22-07-20269 days before the deadline
2025micro format
Gross margin from €16,305 to €100,875Result from €12,789 to €79,311Equity from €15,289 to €94,600Debts from €16,574 to €22,516Cash from €2,434 to €55,929

Key points

from the 2025 annual accounts

Result

€79,311 ▲ 520%
€12,8002024€79,3002025

The result rose in 2025 from €12,789 to €79,311.

Investments

€7,798 9.3 × depreciation

Green is investment, beige is depreciation.

Liquidity

4.89 was 2.20 in 2024

Short-term debts rose from €14,474 to €22,516.

Checked score

98
Excellent
Financially stronger than 86% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2025: 0.1% 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100+27equity 80.8% of total assets
94+57short-term debt 19.2% · cash 47.8%
100=return on assets 67.7%

Score breakdown

lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 4.89, cash €55,929
Equity €94,600 (80.8% of total assets)
Figures for financial year 2025 (filed on 22-07-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 81% on liquidity, 80% on profitability and 99% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as Philotax has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of Philotax itself is lower: < 0.1% within 12 months. It rests on far more data about Philotax than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for Philotax. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record

Liquidity is ample, with a current ratio of 4.89 (2.2 in 2024), above the usual 1.5. Short-term debt is 19.2% and cash 47.8% of total assets. 19.2% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.89, cash €55,929
NBB · annual accounts
lowers risk · Equity €94,600 (80.8% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 22-07-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
9 days early
2024
7 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 1 day before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Board and ownership

  • VANHOOREBEECK Cedric 100 sharesdeed of 04-10-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1014546160
Incorporation Founding capital of €2,500, 100 shares · Founder: VANHOOREBEECK Cedric · Appointment: VANHOOREBEECK Cedric (director) · published on 04-10-2024 · Gazette deed
First establishment Wittemoerstraat 2, Beernem
All 6 events

Comparable companies

same main activity, similar in size and age
Company
Philotax Beernem €117,116 €100,875 80.8% -
Medisch G. Sierens Bruges €109,995 €104,821 72.1% -
SALMONCO Neupré €119,799 €102,969 79.4% -
LERIX Grobbendonk €118,998 €104,960 76.5% -
DOCTEUR MARION HUBERT Waremme €120,234 €95,440 86.1% -
société médicale Fanny KAESMACHER Donceel €116,510 €94,980 65.3% -
Docteur A. IANCU Seraing €126,521 €107,834 1.2% -

These companies have the same main activity as Philotax: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €110,000 and €127,000, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 02-10-2024Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment unit
2.365.264.5298730 Beernem, since 02-10-2024
Financial year end
31 December
Peppol
Reachable since 16-01-2026
Company details

Annual accounts 2025

≈ €190,000estimated
€117,116▲ 268%
Filing
Filed on 22-07-2026, 9 days before the end of the filing period
Financials

Insights on Philotax

Philotax has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €94,600 and a net result of €79,311.

Its solvency ranks better than 71% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Philotax

What is the company number of Philotax?
The company number of Philotax is 1014.546.160. The VAT number is the same number with BE in front: BE 1014.546.160.
Where is Philotax based?
The registered office is at Wittemoerstraat 2, 8730 Beernem.Company details
What does Philotax do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Philotax?
Philotax is a private limited company (BV).
When was Philotax founded?
Philotax was founded on 02-10-2024.
Is Philotax still active?
Yes, Philotax is an active enterprise in the KBO register.
What is the turnover of Philotax?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €100,875 and 41 comparable companies (NACE 86220). It probably lies between €160,000 and €250,000.Financials
Is Philotax profitable?
In financial year 2025, Philotax made a profit of €79,311.
Where can I find the annual accounts of Philotax?
Philotax filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Philotax due?
Philotax must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.